These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2645709)

  • 21. Risk factors for cadaveric donor allograft survival in cyclosporine-prednisone-treated recipients.
    Kahan BD; Mickey R; Flechner SM; Lorber MI; Wideman CA; Kerman RH; Terasaki P; Van Buren CT
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1835-8. PubMed ID: 3547890
    [No Abstract]   [Full Text] [Related]  

  • 22. Kidney transplantation in diabetic patients using cyclosporine. Five-year follow-up.
    Shaffer D; Simpson MA; Madras PN; Sahyoun AI; Conway PA; Davis CP; Monaco AP
    Arch Surg; 1995 Mar; 130(3):283-7; discussion 287-8. PubMed ID: 7887795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Causes of graft loss beyond two years in the cyclosporine era.
    Dunn J; Golden D; Van Buren CT; Lewis RM; Lawen J; Kahan BD
    Transplantation; 1990 Feb; 49(2):349-53. PubMed ID: 2305464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal transplantation at the University of Pennsylvania Medical Center: an update of results in the cyclosporine era.
    Brayman KL; Egidi FM; Naji A; Friedman AL; Perloff L; Grossman R; Zmijewski CM; Cameron E; Kobrin S; Feldman H
    Clin Transpl; 1992; ():215-25. PubMed ID: 1306700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal transplantation done safely without prior chronic dialysis therapy.
    Migliori RJ; Simmons RL; Payne WD; Ascher NL; Sutherland DE; Najarian JS; Fryd D
    Transplantation; 1987 Jan; 43(1):51-5. PubMed ID: 3541323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adult-size kidneys without acute tubular necrosis provide exceedingly superior long-term graft outcomes for infants and small children: a single center and UNOS analysis. United Network for Organ Sharing.
    Sarwal MM; Cecka JM; Millan MT; Salvatierra O
    Transplantation; 2000 Dec; 70(12):1728-36. PubMed ID: 11152105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intermediate-term outcome of renal retransplants in the cyclosporine era.
    Sumrani NB; Miles AM; Daskalakis P; Hong JH; Markell MS; Friedman EA; Sommer BG
    ASAIO J; 1993; 39(1):47-50. PubMed ID: 8439680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sequential use of Minnesota antilymphoblast globulin and cyclosporine in cadaveric renal transplantation.
    Kupin WL; Venkatachalam KK; Oh HK; Dienst S; Levin NW
    Transplantation; 1985 Dec; 40(6):601-4. PubMed ID: 3907029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Examination of parameters influencing the benefit:detriment ratio of cyclosporine in renal transplantation. The Canadian Transplant Study Group.
    Am J Kidney Dis; 1985 Jun; 5(6):328-32. PubMed ID: 3925763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complications of cyclosporine-prednisone immunosuppression in 402 renal allograft recipients exclusively followed at a single center for from one to five years.
    Kahan BD; Flechner SM; Lorber MI; Golden D; Conley S; Van Buren CT
    Transplantation; 1987 Feb; 43(2):197-204. PubMed ID: 3544376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cadaveric renal transplantation: surgical results and expectations in the cyclosporine era.
    Koyle MA; Ward HJ; Klein SR; Williams RA; White GH; Butler JA; Sender MB; Rajfer J
    J Urol; 1988 Mar; 139(3):493-6. PubMed ID: 3278127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pediatric kidney transplantation and living donors--invaluable by virtue of necessity].
    Leumann E; Goetschel P; Neuhaus TJ; Ambühl PM; Candinas D
    Schweiz Med Wochenschr; 2000 Oct; 130(43):1581-9. PubMed ID: 11100511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The UNOS Scientific Renal Transplant Registry.
    Cecka JM
    Clin Transpl; 1999; ():1-21. PubMed ID: 11038622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized trial comparing cyclosporine with antilymphoblast-globulin-azathioprine for renal allograft recipients. Results at 2 1/2-6 years.
    Johnson CP; Simmons RL; Sutherland DE; Canafax DM; Ascher NL; Payne WD; Flick B; Najarian JS; Fryd DS
    Transplantation; 1988 Feb; 45(2):380-5. PubMed ID: 3278431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved patient and primary renal allograft survival in uremic diabetic recipients.
    Sutherland DE; Morrow CE; Fryd DS; Ferguson R; Simmons RL; Najarian JS
    Transplantation; 1982 Dec; 34(6):319-25. PubMed ID: 6818738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2,500 living donor kidney transplants: a single-center experience.
    Matas AJ; Payne WD; Sutherland DE; Humar A; Gruessner RW; Kandaswamy R; Dunn DL; Gillingham KJ; Najarian JS
    Ann Surg; 2001 Aug; 234(2):149-64. PubMed ID: 11505060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of 2-drug and 3-drug immunosuppression for cadaveric renal transplantation.
    Martin DC; Tertzakian G; Ruzics E
    J Urol; 1990 May; 143(5):900-1. PubMed ID: 2329602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal transplantation in Mississippi.
    Butkus DE; Kirchner KA; Krueger RP; Raju SS
    J Miss State Med Assoc; 1990 Apr; 31(4):105-10. PubMed ID: 2332887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of dietary fish oil on renal function and rejection in cyclosporine-treated recipients of renal transplants.
    van der Heide JJ; Bilo HJ; Donker JM; Wilmink JM; Tegzess AM
    N Engl J Med; 1993 Sep; 329(11):769-73. PubMed ID: 8350886
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-dose cyclosporine therapy combined with standard immunosuppression in pediatric renal transplantation.
    So SK; Najarian JS; Nevins TE; Fryd DS; Knaak M; Chavers B; Mauer SM; Simmons RL
    J Pediatr; 1987 Dec; 111(6 Pt 2):1017-21. PubMed ID: 3316573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.